Literature DB >> 33975383

Inactivation of soluble guanylyl cyclase in living cells proceeds without loss of haem and involves heterodimer dissociation as a common step.

Yue Dai1, Dennis J Stuehr1.   

Abstract

BACKGROUND AND
PURPOSE: Nitric oxide (NO) activates soluble guanylyl cyclase (sGC) for cGMP production, but in disease, sGC becomes insensitive towards NO activation. What changes occur to sGC during its inactivation in cells is not clear. EXPERIMENTAL APPROACH: We utilized HEK293 cells expressing sGC proteins to study the changes that occur regarding its haem content, heterodimer status and sGCβ protein partners when the cells were given the oxidant ODQ or the NO donor NOC12 to inactivate sGC. Haem content of sGCβ was monitored in live cells through use of a fluorescent-labelled sGCβ construct, whereas sGC heterodimer status and protein interactions were studied by Western blot analysis. Experiments with purified proteins were also performed. KEY
RESULTS: ODQ- or NOC12-driven inactivation of sGC in HEK293 cells was associated with haem oxidation (by ODQ), S-nitrosation of the sGCβ subunit (by NOC12), sGC heterodimer breakup and association of the freed sGCβ subunit with cell chaperone Hsp90. These changes occurred without detectable loss of haem from the sGCβ reporter construct. Treating a purified ferrous haem-containing sGCβ with ODQ or NOC12 caused it to bind with Hsp90 without showing any haem loss. CONCLUSION AND IMPLICATIONS: Oxidative (ODQ) or nitrosative (NOC12) inactivation of cell sGC involves sGC heterodimer dissociation and rearrangement of the sGCβ protein partners without any haem loss from sGCβ. Clarifying what changes do and do not occur to sGC during its inactivation in cells may direct strategies to preserve or recover NO-dependent cGMP signalling in health and disease. LINKED ARTICLES: This article is part of a themed issue on cGMP Signalling in Cell Growth and Survival. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.11/issuetoc.
© 2021 The British Pharmacological Society.

Entities:  

Keywords:  FlAsH probe; S-nitros ation; cGMP; haem; nitric oxide; protein interaction

Mesh:

Substances:

Year:  2021        PMID: 33975383      PMCID: PMC9484448          DOI: 10.1111/bph.15527

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   9.473


  52 in total

1.  Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation.

Authors:  Nazish Sayed; Padmamalini Baskaran; Xiaolei Ma; Focco van den Akker; Annie Beuve
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-16       Impact factor: 11.205

2.  Identification of novel S-nitrosation sites in soluble guanylyl cyclase, the nitric oxide receptor.

Authors:  Annie Beuve; Changgong Wu; Chuanlong Cui; Tong Liu; Mohit Raja Jain; Can Huang; Lin Yan; Vladyslav Kholodovych; Hong Li
Journal:  J Proteomics       Date:  2016-02-18       Impact factor: 4.044

Review 3.  Thiol-Based Redox Modulation of Soluble Guanylyl Cyclase, the Nitric Oxide Receptor.

Authors:  Annie Beuve
Journal:  Antioxid Redox Signal       Date:  2016-04-01       Impact factor: 8.401

Review 4.  Redox regulation of soluble guanylyl cyclase.

Authors:  Rohan C Shah; Subramaniam Sanker; Katherine C Wood; Brittany G Durgin; Adam C Straub
Journal:  Nitric Oxide       Date:  2018-03-22       Impact factor: 4.427

5.  GAPDH delivers heme to soluble guanylyl cyclase.

Authors:  Yue Dai; Elizabeth A Sweeny; Simon Schlanger; Arnab Ghosh; Dennis J Stuehr
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

6.  A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation.

Authors:  Emil Martin; Iraida Sharina; Alexander Kots; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

7.  BAY 58-2667, a nitric oxide-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts.

Authors:  Thomas Krieg; Yanping Liu; Thomas Rütz; Carmen Methner; Xi-Ming Yang; Turhan Dost; Stephan B Felix; Johannes-Peter Stasch; Michael V Cohen; James M Downey
Journal:  Eur Heart J       Date:  2009-04-30       Impact factor: 29.983

8.  Soluble guanylyl cyclase requires heat shock protein 90 for heme insertion during maturation of the NO-active enzyme.

Authors:  Arnab Ghosh; Dennis J Stuehr
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-25       Impact factor: 11.205

9.  Inactivation of soluble guanylate cyclase by stoichiometric S-nitrosation.

Authors:  Bernd Mayer; Andrei L Kleschyov; Heike Stessel; Michael Russwurm; Thomas Münzel; Doris Koesling; Kurt Schmidt
Journal:  Mol Pharmacol       Date:  2008-12-29       Impact factor: 4.436

10.  Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice.

Authors:  Robrecht Thoonen; Anje Cauwels; Kelly Decaluwe; Sandra Geschka; Robert E Tainsh; Joris Delanghe; Tino Hochepied; Lode De Cauwer; Elke Rogge; Sofie Voet; Patrick Sips; Richard H Karas; Kenneth D Bloch; Marnik Vuylsteke; Johannes-Peter Stasch; Johan Van de Voorde; Emmanuel S Buys; Peter Brouckaert
Journal:  Nat Commun       Date:  2015-10-07       Impact factor: 14.919

View more
  2 in total

1.  Sex-Dependent Effect of Platelet Nitric Oxide: Production and Platelet Reactivity in Healthy Individuals.

Authors:  Matthew D Godwin; Anu Aggarwal; Zachary Hilt; Shalini Shah; Joshua Gorski; Scott J Cameron
Journal:  JACC Basic Transl Sci       Date:  2021-12-08

2.  NO rapidly mobilizes cellular heme to trigger assembly of its own receptor.

Authors:  Yue Dai; Emily M Faul; Arnab Ghosh; Dennis J Stuehr
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 12.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.